Single-use Assemblies Market Size & Growth Forecast 2026–2035, By Segments (Solution, End-use, Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Single-use Assemblies Market size was more than USD 15.43 Billion in 2025 and is set to grow at a 16.4% CAGR between 2026 and 2035, surpassing USD 70.45 Billion by 2035. The industry revenue for 2026 is assessed at USD 17.68 billion.
Get more details on this report
Request Free Sample ReportSingle-use Assemblies Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 39.42% share due to mature biopharmaceutical manufacturing, early adoption of disposable systems, and strong demand from CDMOs and large biologics producers.
- Asia Pacific is growing at 18.37% CAGR driven by expanding biomanufacturing capacity, rapid facility buildouts, and adoption of flexible disposable systems to reduce setup time and costs.
Segment Momentum
- Customized Solutions captured a 68.84% share in 2025 because bioprocessing facilities require assemblies tailored to specific workflows, equipment compatibility, sterility needs, and process integration while reducing contamination risks.
- CROs & CMOs are the fastest-growing end users because single-use assemblies provide the flexibility, rapid changeovers, and modular production capabilities needed for multi-client outsourced manufacturing environments.
Market Expansion Drivers
- Expanding biologics production driving widespread adoption of single-use bioprocessing systems.
- Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration.
- Sustainable recyclable single-use systems reducing waste and improving regulatory compliance.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading companies in the single-use assemblies market include Thermo Fisher Scientific Inc. (United States), Merck KGaA (Germany), Sartorius AG (Germany), Danaher Corporation (United States), Avantor, Inc. (United States), Lonza Group AG (Switzerland), Saint-Gobain S.A. (France), Corning Incorporated (United States), Entegris, Inc. (United States), KUHNER AG (Switzerland).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As biologics pipelines move from clinical development into commercial manufacturing, producers are scaling capacity while trying to avoid the long lead times and cleaning validation burden associated with fixed stainless-steel infrastructure. That shift directly supports demand for the single-use assemblies market because disposable tubing sets, bags, connectors, filters, and manifolds are embedded in upstream and downstream workflows that need rapid changeover, contamination control, and batch flexibility. In practice, facilities expanding monoclonal antibody, cell therapy, and other biologics output often standardize around single-use process trains to shorten commissioning timelines and accommodate multi-product manufacturing, driving market development for preconfigured assemblies tailored to specific bioprocess steps.
Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration
Rising biopharmaceutical R&D activity is increasing the number of small-batch, high-variation process runs, a production profile that favors modular and quickly deployable fluid handling solutions. This is reinforcing market demand for the single-use assemblies market as development labs, pilot plants, and contract manufacturing organizations integrate ready-to-use assemblies to reduce setup complexity, limit cross-batch contamination risk, and support faster tech transfer from process development to clinical and commercial production. CMOs are especially influential because their business model depends on flexible suites that can be reconfigured for multiple clients, making disposable assemblies a practical operating choice rather than a peripheral consumables decision.
Sustainable recyclable single-use systems reducing waste and improving regulatory compliance
Pressure to reduce process waste is changing procurement priorities from purely convenience-driven disposable use toward systems designed for recyclability, material traceability, and more controlled end-of-life handling. That evolution is influencing adoption in the single-use assemblies market by pushing suppliers to develop assemblies that align with sustainability targets without disrupting sterility assurance or process performance, while also helping manufacturers document waste streams and material compliance more effectively. In regulated bioprocessing environments, these features matter because environmental reporting expectations and internal ESG commitments increasingly shape equipment selection, contributing to market size growth for higher-value single-use formats that address both operational and compliance requirements.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding biologics production driving widespread adoption of single-use bioprocessing systems | 2.10% | High | North America, Europe | High | Near Term |
| Increasing biopharmaceutical R&D and CMOs accelerating disposable assembly integration | 1.80% | High | Asia Pacific, North America | High | Near Term |
| Sustainable recyclable single-use systems reducing waste and improving regulatory compliance | 1.50% | High | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 39.42% share of the single-use assemblies market in 2025, backed by its established biopharmaceutical manufacturing base and broad integration of disposable systems across upstream and downstream operations. The region’s leadership is reinforced by mature GMP production infrastructure, early adoption of single-use processing in biologics manufacturing, and steady demand from CDMOs and large drug developers that rely on flexible, contamination-controlled production setups. In practice, this sustains regional market activity because manufacturers can scale batches faster, reduce cleaning validation requirements, and support multiproduct facilities more efficiently.
Asia Pacific is projected to expand at an 18.37% CAGR over the forecast period, driven by the ongoing buildout of biomanufacturing capacity and rising adoption of modular production technologies across emerging pharmaceutical hubs. Growth in the single-use assemblies market is being accelerated by increasing investment in local biologics production, where companies are adopting disposable flow paths and ready-to-use assemblies to shorten facility setup times and lower upfront infrastructure complexity. This practical fit is especially relevant in the region as manufacturers add new capacity, pursue faster commissioning, and align production systems with growing demand for flexible and cost-efficient biologics manufacturing.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Flexible Manufacturing AdoptionGermany is integrating single-use assemblies into bioprocessing facilities to support efficient production of biologics and advanced therapies. German manufacturers are emphasizing modular production strategies that require scalable and contamination-resistant fluid management systems.
France 🇫🇷
Advanced Therapy Manufacturing SupportFrance is increasingly using single-use assemblies in vaccine production and advanced therapy manufacturing. French bioprocessing facilities are prioritizing flexible systems that enable smaller production batches and facilitate rapid process changes without extensive downtime.
Italy 🇮🇹
Emerging Biotech Production ToolsItaly is incorporating single-use assemblies into biotechnology and pharmaceutical production environments seeking greater operational agility. Italian manufacturers are adopting disposable process components to improve efficiency while supporting specialized and smaller-scale biologic production programs.
Japan 🇯🇵
Process Efficiency EnhancementJapan is adopting single-use assemblies to streamline biopharmaceutical manufacturing and accelerate process development activities. Companies in Japan are seeking standardized and high-quality disposable systems that reduce cleaning requirements and improve operational consistency.
South Korea 🇰🇷
Biopharma Capacity DevelopmentSouth Korea's growing biopharmaceutical manufacturing sector is creating strong demand for single-use assemblies across upstream and downstream operations. Producers in South Korea are investing in disposable technologies that support rapid facility expansion and contract manufacturing activities.
United States 🇺🇸
Bioprocessing Scale ExpansionThe U.S. single-use assemblies market is closely linked to expanding biologics and cell therapy manufacturing capacity. Biopharmaceutical companies in the U.S. are increasing adoption of pre-sterilized assemblies to improve production flexibility and reduce changeover requirements in multiproduct facilities.
Segment Leadership and Growth Trends
Single-use Assemblies Market Share (%), Solution, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportCustomized Solutions accounted for a 68.84% share of the single-use assemblies market in 2025, reflecting how strongly bioprocessing operations value assemblies tailored to specific workflow, equipment, and regulatory requirements. This segment leads because standardized configurations often fall short in complex production environments where fluid paths, connector compatibility, sterility assurance, and process integration must be closely aligned with plant-level operating conditions. The same practical need is also sustaining its faster growth in the single-use assemblies market, as manufacturers increasingly seek ready-to-deploy assemblies that reduce installation adjustments, limit contamination risk, and support quicker changeovers in biologics production.
End-use Segment Analysis: Biopharmaceutical & Pharmaceutical Companies (Largest Segment) vs CROs & CMOs (Fastest-Growing Segment)
Biopharmaceutical & Pharmaceutical Companies held a 52.42% share of the single-use assemblies market in 2025, making them the leading end-use segment as commercial manufacturing and late-stage development activities continue to require consistent, validated fluid management systems at scale. Their share leadership is reinforced through direct control over production environments, higher volumes of process-intensive operations, and ongoing reliance on single-use assemblies to support sterile transfer, formulation, and fill-finish workflows without adding cleaning complexity to core manufacturing lines.
CROs & CMOs are emerging as the fastest-growing end-use segment in the single-use assemblies market because outsourced development and manufacturing models depend heavily on flexibility across projects, batch sizes, and client process requirements. Single-use assemblies fit this operating model well by enabling faster turnaround between programs and reducing the burden of fixed equipment adaptation. This gives CROs & CMOs stronger momentum relative to other end users, especially where multi-client facilities need modular, rapidly configurable production setups.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Solution | Customized Solutions, Standard Solutions | Customized Solutions | Customized Solutions |
| End-use | Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes | Biopharmaceutical & Pharmaceutical Companies | CROs & CMOs |
| Product | Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Tubing Assemblies, Other | Filtration Assemblies | Bag Assemblies |
| Application | Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish Applications, Other | Filtration | Cell Culture & Mixing |
Competitive Landscape and Market Positioning
1. Thermo Fisher Scientific Inc. (United States)
2. Merck KGaA (Germany)
3. Sartorius AG (Germany)
4. Danaher Corporation (United States)
5. Avantor Inc. (United States)
6. Lonza Group AG (Switzerland)
7. Saint-Gobain S.A. (France)
8. Corning Incorporated (United States)
9. Entegris Inc. (United States)
10. KUHNER AG (Switzerland)
Increasing emphasis on compliance and efficiency is shaping the single-use assemblies market. Innovation in sterile processing and modular system design is improving adaptability across production environments. The single-use assemblies market is also experiencing strong momentum in standardized solutions that support evolving operational requirements.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| SaniSure | Apr-24 | SaniSure commercialized Fill4Sure, a customized single-use filling assembly developed to improve process repeatability, security, and operational efficiency during drug fill steps. |
| Getinge | May-23 | Getinge reached a binding share-acquisition agreement to purchase Purity New England, Inc., capturing its established single-use bioprocessing technology solutions catalog. |
| Merck KGaA | Apr-23 | Merck KGaA launched Ultimus, a high-strength single-use process container film engineered for advanced leak resistance within fluid single-use assemblies. |
| Thermo Fisher Scientific | Apr-22 | Thermo Fisher Scientific established a new single-use bioprocessing manufacturing facility in Utah, USA, as part of a multi-year USD 650 million infrastructure expansion strategy. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Single-use Assemblies Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Single-use Assemblies Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the single-use assemblies market?
What is the anticipated CAGR of the single-use assemblies industry?
How is biologics manufacturing expansion influencing adoption in the single-use assemblies market?
Why are sustainability considerations becoming more important in single-use assemblies procurement?
Why do Customized Solutions dominate the single-use assemblies market?
Why are CROs & CMOs the fastest-growing end users in the single-use assemblies market?
Why does North America lead the single-use assemblies market?
What is fueling Asia Pacific growth in single-use assemblies market?
Who holds a significant market share in the single-use assemblies landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization